Soleno Therapeutics to Participate in Upcoming Conferences Jan 29, 2026 08:00AM
TD Cowen Reiterates Buy on Soleno Therapeutics (SLNO) as Vykat XR Launch Has Exceeds Expectations Sep 11, 2025 08:27AM
TD Cowen on Soleno Therapeutics Inc. (SLNO): 'Patient Death Not Treatment Related; Vykat XR Safety Continues To Be Consistent' Sep 10, 2025 01:46PM
TD Cowen Reiterates Buy Rating on Soleno Therapeutics Inc. (SLNO) Aug 18, 2025 09:39AM
Soleno Therapeutics prices $200 million stock offering at $85 per share Jul 10, 2025 09:08AM


Jul 10, 2025 09:07AM Soleno Therapeutics Announces Pricing of $200 Million Public Offering of Common Stock
Jun 23, 2025 05:31AM TD Cowen Starts Soleno Therapeutics Inc. (SLNO) at Buy
Jun 20, 2025 08:00AM Soleno Therapeutics Announces Multiple Presentations at the 2025 United in Hope: International Prader-Willi Syndrome Conference
Feb 22, 2024 08:00AM Soleno Therapeutics to Present at the TD Cowen 44th Annual Health Care Conference
Nov 15, 2018 08:07AM Soleno Therapeutics (SLNO) Highlights Clinical Data from Phase II Study (PC025) of Diazoxide Choline Controlled Release
Nov 15, 2018 08:05AM Soleno Therapeutics Presents Clinical Fat Loss Data on DCCR at the Obesity Society Meeting 2018
Oct 8, 2018 08:00AM Soleno Therapeutics Presents Clinical Data on DCCR at 2018 Foundation for Prader-Willi Research Annual Conference